EVI-1 oncogene expression predicts survival in chronic-phase CML patients resistant to imatinib treated with second-generation tyrosine kinase inhibitors.
暂无分享,去创建一个
R. Clark | D. Marin | J. Goldman | L. Foroni | G. Gerrard | Mustafa Daghistani | P. May | A. Reid | J. Apperley | Lihui Wang | J. Khorashad | Christos Paliompeis | Valeria A S de Melo | D. Milojkovic
[1] K. Döhner,et al. High EVI1 expression predicts outcome in younger adult patients with acute myeloid leukemia and is associated with distinct cytogenetic abnormalities. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] D. Marin,et al. Early prediction of success or failure of treatment with second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukemia , 2010, Haematologica.
[3] G. Nucifora,et al. EVI1 recruits the histone methyltransferase SUV39H1 for transcription repression , 2008, Journal of cellular biochemistry.
[4] Jaspal Kaeda,et al. Imatinib for newly diagnosed patients with chronic myeloid leukemia: incidence of sustained responses in an intention-to-treat analysis. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] B. Löwenberg,et al. High EVI1 levels predict adverse outcome in acute myeloid leukemia: prevalence of EVI1 overexpression and chromosome 3q26 abnormalities underestimated. , 2008, Blood.
[6] K. Bhalla,et al. Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is effective in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in chronic phase following imatinib resistance and intolerance. , 2007, Blood.
[7] M. Baccarani,et al. Dasatinib induces notable hematologic and cytogenetic responses in chronic-phase chronic myeloid leukemia after failure of imatinib therapy. , 2007, Blood.
[8] R. Wieser,et al. Quantitative comparison of the expression of EVI1 and its presumptive antagonist, MDS1/EVI1, in patients with myeloid leukemia , 2003, Genes, chromosomes & cancer.
[9] N. Kamada,et al. Abnormal expression of Evi-1 gene in human leukemias. , 1996, Human cell.
[10] K. Tanaka,et al. Increased Evi-1 expression is frequently observed in blastic crisis of chronic myelocytic leukemia. , 1996, Leukemia.